145 related articles for article (PubMed ID: 32769996)
1. Effect of allosteric inhibition of non-muscle myosin 2 on its intracellular diffusion.
Horváth ÁI; Gyimesi M; Várkuti BH; Képiró M; Szegvári G; Lőrincz I; Hegyi G; Kovács M; Málnási-Csizmadia A
Sci Rep; 2020 Aug; 10(1):13341. PubMed ID: 32769996
[TBL] [Abstract][Full Text] [Related]
2. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction.
Wang HH; Tanaka H; Qin X; Zhao T; Ye LH; Okagaki T; Katayama T; Nakamura A; Ishikawa R; Thatcher SE; Wright GL; Kohama K
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2060-8. PubMed ID: 18296570
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor.
Duxbury MS; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Jan; 313(4):992-7. PubMed ID: 14706640
[TBL] [Abstract][Full Text] [Related]
4. The structural basis of blebbistatin inhibition and specificity for myosin II.
Allingham JS; Smith R; Rayment I
Nat Struct Mol Biol; 2005 Apr; 12(4):378-9. PubMed ID: 15750603
[TBL] [Abstract][Full Text] [Related]
5. Specificity of blebbistatin, an inhibitor of myosin II.
Limouze J; Straight AF; Mitchison T; Sellers JR
J Muscle Res Cell Motil; 2004; 25(4-5):337-41. PubMed ID: 15548862
[TBL] [Abstract][Full Text] [Related]
6. para-Nitroblebbistatin, the non-cytotoxic and photostable myosin II inhibitor.
Képiró M; Várkuti BH; Végner L; Vörös G; Hegyi G; Varga M; Málnási-Csizmadia A
Angew Chem Int Ed Engl; 2014 Jul; 53(31):8211-5. PubMed ID: 24954740
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin.
Eddinger TJ; Meer DP; Miner AS; Meehl J; Rovner AS; Ratz PH
J Pharmacol Exp Ther; 2007 Feb; 320(2):865-70. PubMed ID: 17132816
[TBL] [Abstract][Full Text] [Related]
8. Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs.
Verhasselt S; Stevens CV; Van den Broecke T; Bracke ME; Roman BI
Bioorg Med Chem Lett; 2017 Jul; 27(13):2986-2989. PubMed ID: 28512027
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Blebbistatin Inhibition of Smooth Muscle Myosin and Nonmuscle Myosin-2.
Zhang HM; Ji HH; Ni T; Ma RN; Wang A; Li XD
Biochemistry; 2017 Aug; 56(32):4235-4243. PubMed ID: 28714309
[TBL] [Abstract][Full Text] [Related]
10. Myosin II isoform co-assembly and differential regulation in mammalian systems.
Beach JR; Hammer JA
Exp Cell Res; 2015 May; 334(1):2-9. PubMed ID: 25655283
[TBL] [Abstract][Full Text] [Related]
11. Discovery of (S)-3'-hydroxyblebbistatin and (S)-3'-aminoblebbistatin: polar myosin II inhibitors with superior research tool properties.
Verhasselt S; Roman BI; De Wever O; Van Hecke K; Van Deun R; Bracke ME; Stevens CV
Org Biomol Chem; 2017 Mar; 15(9):2104-2118. PubMed ID: 28220174
[TBL] [Abstract][Full Text] [Related]
12. Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
Roman BI; Verhasselt S; Stevens CV
J Med Chem; 2018 Nov; 61(21):9410-9428. PubMed ID: 29878759
[TBL] [Abstract][Full Text] [Related]
13. Regulation of polarity in cells devoid of actin bundle system after treatment with inhibitors of myosin II activity.
Shutova MS; Alexandrova AY; Vasiliev JM
Cell Motil Cytoskeleton; 2008 Sep; 65(9):734-46. PubMed ID: 18615701
[TBL] [Abstract][Full Text] [Related]
14. A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative.
Várkuti BH; Képiró M; Horváth IÁ; Végner L; Ráti S; Zsigmond Á; Hegyi G; Lenkei Z; Varga M; Málnási-Csizmadia A
Sci Rep; 2016 May; 6():26141. PubMed ID: 27241904
[TBL] [Abstract][Full Text] [Related]
15. Activation of myosin in HeLa cells causes redistribution of focal adhesions and F-actin from cell center to cell periphery.
Szczepanowska J; Korn ED; Brzeska H
Cell Motil Cytoskeleton; 2006 Jun; 63(6):356-74. PubMed ID: 16607629
[TBL] [Abstract][Full Text] [Related]
16. Myosin phosphatase targeting subunit 1 affects cell migration by regulating myosin phosphorylation and actin assembly.
Xia D; Stull JT; Kamm KE
Exp Cell Res; 2005 Apr; 304(2):506-17. PubMed ID: 15748895
[TBL] [Abstract][Full Text] [Related]
17. Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs.
Verhasselt S; Roman BI; Bracke ME; Stevens CV
Eur J Med Chem; 2017 Aug; 136():85-103. PubMed ID: 28486210
[TBL] [Abstract][Full Text] [Related]
18. Block the function of nonmuscle myosin II by blebbistatin induces zebrafish embryo cardia bifida.
Wang X; Chong M; Wang X; Wang H; Zhang J; Xu H; Zhang J; Liu D
In Vitro Cell Dev Biol Anim; 2015 Mar; 51(3):211-7. PubMed ID: 25403653
[TBL] [Abstract][Full Text] [Related]
19. The selective role of myosin VI in lymphoid leukemia cell migration.
Jbireal JM; Strell C; Niggemann B; Zänker K; Entschladen F
Leuk Res; 2010 Dec; 34(12):1656-62. PubMed ID: 20493527
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
